Independently trialled,
tested and results verified.
-
Independent Published Peer Reviewed Paper of CASPR in an Intensive Care Unit
The introduction of continuous low-level gaseous H2O2 on all surfaces throughout the ICU reduced the overall bacterial and fungal microbial burden by 95%, as well as lowered the incidence of both MRSA and VRE on surfaces by 81%, and decreased the monthly average onset HAI rate by 54%.
-
Independent Lab Report - The University of Wisconsin
Test for SARs-CoV-2 inactivation on surfaces using ReSPR and CASPR’s continuous disinfection technology in 2020.
-
Independent Lab Report - Aersol Research and Engineering Laboratories
Report on the efficacy of CASPR and competing products to reduce surface and airborne Staphylococcus Epidermis.
-
Independent Lab Report - Microchem Laboratory
Report on the efficacy of CASPRs NSCI technology utilised in the CASPR induct device to continuously reduce pathogens on surfaces.
-
NCC Technology - Class 1 Medical Device Certificate
Declaration that ReSPR Technologies sanitizer products conform as a Class 1 Medical Device in accordance with the standards of UNI EN ISO 1705:1-20101 and UNI EN ISO 17050-2:2005.
-
Bureau Veritas IAQ-ASE® Certification
Bureau Veritas Italia S.p.A. validates the technical specification of the IAQ-ASE® Continuous Active Sanitisation method in relation to indoor air quality, and issues a certificate conformity to IAQ-ASE®.
-
Hilton DoubleTree achieves IAQ-ASE® Certification
Hilton DoubleTree Hotel in Italy installs ReSPRs NCC technology. Bureau Veritas issue certificate conformity in relation to the Hotel meeting the technical specification of the IAQ-ASE® Continuous Active Sanitisation method (certificate No. IT.3785755).